Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.11124/JBIES-20-00516 http://scihub22266oqcxt.onion/10.11124/JBIES-20-00516 34341310!8728762!34341310     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       JBI+Evid+Synth 2022 ; 20 (1): 158-163 Nephropedia Template TP {{tp|p=34341310|t=2022. Prevalence of COVID-19 genomic variation in Africa: a living systematic review protocol |pdf=|usr=}}{{34341310}} gab.com Text Prevalence of COVID-19 genomic variation in Africa: a living systematic review protocol JO: JBI Evid Synth http://www.kidney.de/pget.php?&tw=1&pmid=34341310 #FOAvip OBJECTIVE: The objective of this living systematic review is to synthesize the available evidence on the prevalence of types of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genomic variations in Africa. INTRODUCTION: The burden of the coronavirus disease 2019 (COVID-19) pandemic on the health, well-being, and global economy (especially the fragile economies of African countries) is significant. Profiling the genomic and geographical variations of SARS-CoV-2, a causative agent of COVID-19, may be important for future decision-making, policy guidelines, and development of drugs and vaccines. However, little is known about the up-to-date prevalence of genomic and geographical variations of SARS-CoV-2 virus on the African continent. INCLUSION CRITERIA: This living systematic review will include studies on the prevalence of SARS-CoV-2 genetic strains and mutations obtained from sequencing data of samples from individuals of all ages and sexes using the next generation sequencing approaches in studies conducted in Africa. METHODS: The search strategy will be developed to retrieve both published and unpublished data. Published data will be obtained from electronic databases. Unpublished data will be obtained from conference proceedings, preprints, theses/dissertations, electronic search engines, and COVID-19-dedicated websites. Relevant published or unpublished data in the English language from January 2020 will be considered. Studies will be selected based on the inclusion criteria of the review. The selected studies will be critically appraised for methodological quality by two independent reviewers and data extracted from eligible studies. Finally, meta-analysis will be done, if feasible, to pool prevalence estimates after heterogeneity of the data has been analyzed. SYSTEMATIC REVIEW REGISTRATION NUMBER: PROSPERO CRD42020211451. Twit Text FOAVip Prevalence of COVID-19 genomic variation in Africa: a living systematic review protocol ????JBI Evid Synth http://www.kidney.de/pget.php?&tw=1&pmid=34341310 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34341310 #FOAvip English Wikipedia <ref>{{Cite pmid|34341310}}</ref> Prevalence of COVID-19 genomic variation in Africa: a living systematic review protocol #MMPMID34341310 Adjei G; Enuameh YA; Thomford NE JBI Evid Synth 2022[Jan]; 20 (1): 158-163 PMID34341310show ga OBJECTIVE: The objective of this living systematic review is to synthesize the available evidence on the prevalence of types of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genomic variations in Africa. INTRODUCTION: The burden of the coronavirus disease 2019 (COVID-19) pandemic on the health, well-being, and global economy (especially the fragile economies of African countries) is significant. Profiling the genomic and geographical variations of SARS-CoV-2, a causative agent of COVID-19, may be important for future decision-making, policy guidelines, and development of drugs and vaccines. However, little is known about the up-to-date prevalence of genomic and geographical variations of SARS-CoV-2 virus on the African continent. INCLUSION CRITERIA: This living systematic review will include studies on the prevalence of SARS-CoV-2 genetic strains and mutations obtained from sequencing data of samples from individuals of all ages and sexes using the next generation sequencing approaches in studies conducted in Africa. METHODS: The search strategy will be developed to retrieve both published and unpublished data. Published data will be obtained from electronic databases. Unpublished data will be obtained from conference proceedings, preprints, theses/dissertations, electronic search engines, and COVID-19-dedicated websites. Relevant published or unpublished data in the English language from January 2020 will be considered. Studies will be selected based on the inclusion criteria of the review. The selected studies will be critically appraised for methodological quality by two independent reviewers and data extracted from eligible studies. Finally, meta-analysis will be done, if feasible, to pool prevalence estimates after heterogeneity of the data has been analyzed. SYSTEMATIC REVIEW REGISTRATION NUMBER: PROSPERO CRD42020211451. |*COVID-19[MESH] |Genomics[MESH] |Humans[MESH] |Pandemics[MESH] |Prevalence[MESH] |SARS-CoV-2[MESH]Prevalence of COVID-19 genomic variation in Africa: a living systemati(epmc).pdf DeepDyve Pubget Overpricing